Testosterone Replacement Therapy Market covers Size, Share, Upcoming Trends Segmentation, Opportunities and Forecast
Testosterone deficiency, also known as
hypogonadism, is characterized by impaired male gonad function, which reduces
testosterone secretion. This is caused primarily by hypothalamic-pituitary axis
dysfunction and/or testicular failure.
Testosterone replacement therapy (TRT), also
known as androgen replacement therapy, is one of the most widely used types of
hormone replacement therapy worldwide. It entails the replacement of
testosterone hormone, particularly in male patients suffering from
hypogonadism, low testosterone levels, and/or low libido.
Several pharmaceutical companies have
introduced a diverse range of TRT drugs to the global market. TRT medications
are available in six different formulations: gels or creams, injections,
implants, patches, buccal adhesives, and orals. Testosterone, methyltestosterone, and testosterone esters such as testosterone undecanoate,
testosterone enanthate, and testosterone cypionate are key ingredients used in
various product forms.
Testosterone is the primary male hormone that
regulates male sexual characteristics, spermatogenesis, and fertility. Erectile
dysfunction is caused by insufficient testosterone production. Erectile
dysfunction occurs as a result of decreased testosterone production, and the testosterone
replacement therapy market is used to address the issue. Testosterone
deficiency, also known as hypogonadism, is a common problem among men aged 40
to 79. According to a study published in the National Center for Biotechnology
Information (NCBI), hypogonadism affects approximately 30% of men worldwide.
According to the Boston University School of Medicine, approximately 4 to 5
million men in the United States have hypogonadism, and low testosterone levels
are common in older males. Furthermore, more than 60% of men over the age of 65
have free testosterone levels that are lower than the normal range for men aged
30 to 35.
AbbVie, Inc., Allergan plc, Bayer AG, Endo
Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc,
Mylan N.V., Novartis AG, and Pfizer, Inc. are among the key players profiled in
the Testosterone Replacement Therapy market. Assignable in a company profile
includes a company summary, financial summary, business strategy and planning,
SWOT analysis, and current developments.
Comments
Post a Comment